Neuromuscular disorders (NMDs) cause muscle weakness and degeneration due to nerve-related dysfunction or genetic abnormalities. Conventional treatments primarily focus on symptom relief, but emerging gene therapies and nucleic acid-based solutions offer the potential for long-term disease